Belite Bio BLTE
NASDAQ BLTE
$186.35 +15.26 (+8.92%)
As of: Sep 4, 2026 · 2:28 PM EDT

Belite Bio (BLTE) Shares Outstanding (Entity) (2020 - 2025)

Analysis

Belite Bio (BLTE) Shares Outstanding (Entity) (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 214.24 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 575.00 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 218.28 Mn
10 Belite Bio 6.26 Bn 6.26 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 39.34 Mn
Dec 31, 2024 31.83 Mn
Dec 31, 2023 29.15 Mn
Dec 31, 2022 19.98 Mn
Dec 31, 2021 10.27 Mn
Dec 31, 2020 9.57 Mn